Evaluate the Efficacy and Safety of TF0023 in Treatments for COVID-19 in Hospitalized Adults
NCT05212818
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
19
Enrollment
INDUSTRY
Sponsor class
Stopped
Low patient accrual.
Conditions
COVID-19 Pneumonia
Interventions
DRUG:
TF0023
Sponsor
Techfields Inc